Software as a medical device (#SaMD) continues to evolve with advances in #machinelearning. So do the federal regulations governing these digital tools. @plcerrato and I explain in our latest blog: https://www.mayoclinicplatform.org/2022/06/13/keeping-up-to-date-on-samd-regulations/
Did you see this? A review of public comments on a proposed FDA regulatory framework for modifications to #AI and #machinelearning based software as a medical device has found that 63% came from parties with financial ties to industry. http://ow.ly/hAWE50C5cIu https://t.co/aFTQHYcLAh
FDA has been requesting feedback on their proposed AI/ML Software-as-Medical-Device (SaMD) framework, and our comments (@BpGenetics) were just published. Check out the thread below! #SaMD #AI #MachineLearning #healthcare https://t.co/ldvn3htE3h
FDA has proposed a #regulatory framework for modifications to #ArtificialIntelligence & #MachineLearning based software as a medical device. Seeking public comment Preview 1st few pages below then read full proposal or comment here: http://bit.ly/2FSw3OG. #AACR19 https://t.co/hLg0ErlNwc
Please check out and comment on #FDA’s proposed framework for regulation of #ArtificialIntelligence Intelligence and #MachineLearning “software as medical device” applications https://www.regulations.gov/docket?D=FDA-2019-N-1185
Excited about today’s announcement: FDA’s Digital Health team released a discussion paper with steps to consider a tailored framework for regulating #AI / #MachineLearning medical device software #samd #digitalhealth https://www.fda.gov/downloads/MedicalDevices/DigitalHealth/SoftwareasaMedicalDevice/UCM635052.pdf https://t.co/UZ4VyYLtk4
